Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2009

01-10-2009 | Original Article

Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease

Authors: Patrick Chamouard, Fanny Monneaux, Zoe Richert, Anne-Claire Voegeli, Thomas Lavaux, Marie Pierre Gaub, René Baumann, Pierre Oudet, Sylviane Muller

Published in: Digestive Diseases and Sciences | Issue 10/2009

Login to get access

Abstract

Crohn’s disease is considered to be caused either by an excess of T-cell effector functions and/or by a defective regulatory T-cell compartment. The aim of this study was to assess in Crohn’s disease the frequency of circulating CD4+CD25high T cells that possess regulatory T-cell functions and CD4+CD25low T cells that contain activated T cells. Flow cytometry of peripheral blood was used to assess CD4+CD25high and CD4+CD25low T-cell frequencies in a cohort of 66 patients with Crohn’s disease in comparison to 19 patients with ulcerative colitis and 31 healthy individuals enrolled as controls. The CD4+CD25high T-cell frequency was significantly lowered in naïve Crohn’s disease (P = 0.013) and in ulcerative colitis (P = 0.001). CD4+CD25low T-cell frequency was increased in Crohn’s disease (P = 0.0001) and in ulcerative colitis (P = 0.0002). Both CD4+CD25high and CD4+CD25low T-cell frequencies are altered in naïve Crohn’s disease resulting in an imbalance between both populations and a relative contraction of the CD4+CD25high T-cell population.
Literature
6.
go back to reference Powrie F, Leach MW, Mauze S, Caddle MB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic inflammation in C B-17 SCID mice. Int Immuno. 1993;5:1461–1471. doi:10.1093/intimm/5.11.1461.CrossRef Powrie F, Leach MW, Mauze S, Caddle MB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic inflammation in C B-17 SCID mice. Int Immuno. 1993;5:1461–1471. doi:10.​1093/​intimm/​5.​11.​1461.CrossRef
7.
go back to reference Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med. 1994;179:589–600. doi:10.1084/jem.179.2.589.PubMedCrossRef Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med. 1994;179:589–600. doi:10.​1084/​jem.​179.​2.​589.PubMedCrossRef
10.
go back to reference Mottet C, Uhlig HH, Powrie F. Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939–3943.PubMed Mottet C, Uhlig HH, Powrie F. Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939–3943.PubMed
11.
go back to reference Liu H, Hu B, Xu D, Liew FY. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-β and CTLA4. J Immunol. 2003;171:5012–5017.PubMed Liu H, Hu B, Xu D, Liew FY. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-β and CTLA4. J Immunol. 2003;171:5012–5017.PubMed
13.
16.
go back to reference Cao D, Malmstrom V, Baechler-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003;33:215–223. doi:10.1002/immu.200390024.PubMedCrossRef Cao D, Malmstrom V, Baechler-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003;33:215–223. doi:10.​1002/​immu.​200390024.PubMedCrossRef
20.
go back to reference Lennard-Jones JE. Definition and diagnosis. In: Skandia International Symposia: Regional enteritis (Crohn’s disease). Stockholm: Nordiska Bokhandlen’s Förlag; 1971:105–112. Lennard-Jones JE. Definition and diagnosis. In: Skandia International Symposia: Regional enteritis (Crohn’s disease). Stockholm: Nordiska Bokhandlen’s Förlag; 1971:105–112.
21.
go back to reference Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19(2):5A–36A. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19(2):5A–36A.
22.
go back to reference Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br J Med. 1958;2:1041–1048.CrossRef Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br J Med. 1958;2:1041–1048.CrossRef
27.
28.
go back to reference Esparza EM, Arch RH. Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells. Front Biosci. 2006;11:1448–1465. doi:10.2741/1895.PubMedCrossRef Esparza EM, Arch RH. Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells. Front Biosci. 2006;11:1448–1465. doi:10.​2741/​1895.PubMedCrossRef
29.
31.
go back to reference Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Zack Howard OM. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol. 2006;36:2139–2149. doi:10.1002/eji.200635873.PubMedCrossRef Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Zack Howard OM. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol. 2006;36:2139–2149. doi:10.​1002/​eji.​200635873.PubMedCrossRef
32.
34.
go back to reference Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor2-mediated T helper type 1 responses. Nat Immunol. 2004;5:800–808. doi:10.1038/ni1092.PubMedCrossRef Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor2-mediated T helper type 1 responses. Nat Immunol. 2004;5:800–808. doi:10.​1038/​ni1092.PubMedCrossRef
Metadata
Title
Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease
Authors
Patrick Chamouard
Fanny Monneaux
Zoe Richert
Anne-Claire Voegeli
Thomas Lavaux
Marie Pierre Gaub
René Baumann
Pierre Oudet
Sylviane Muller
Publication date
01-10-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0590-6

Other articles of this Issue 10/2009

Digestive Diseases and Sciences 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine